All In MedTech

FDA Clearance Tracker · P240001-S001

PearlMatrix™ P-15 Peptide Enhanced Bone Graft (PearlMatrix™ Bone Graft)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 11, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P240001-S001
Device name
PearlMatrix™ P-15 Peptide Enhanced Bone Graft (PearlMatrix™ Bone Graft)
Applicant location
Westminster, CO
Received
Sep 8, 2025
Decided
Dec 11, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P240001

Device type

Device class
Class III

Every decision under product code NOX

FDA's approval statement

As written in FDA's record.

Approval to allow implantation of the product using additional open or minimally invasive surgical approaches: ALIF (anterior lumbar interbody fusion), TLIF (transforaminal lumbar interbody fusion), PLIF (posterior lumbar interbody fusion), OLIF/ATP (oblique lumbar interbody fusion/anterior to psoas) and LLIF (lateral lumbar interbody fusion); and approval to allow use of the product with titanium alloy and PEEK/titanium interbody fusion cages, as well as the original PEEK interbody fusion cages.

Source documents

Other decisions for Cerapedics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.